From: Comparison of two malaria multiplex immunoassays that enable quantification of malaria antigens
Category | Samples | Source | Type | Dilution | Matrix | # of samples |
---|---|---|---|---|---|---|
International standard | WHO international standard P. falciparum antigen | NIBSC | Cell culture | 9-points + 1 blank | WB, DBS | 10 |
WHO international standard P. vivax antigen | NIBSC | Pool of clinical | 9-points + 1 blank | WB, DBS | 10 | |
Detection of failed HRP2/HRP3 expression | P. falciparum, W2 (hrp2 + hrp3 +) | PATH | Cell culture | 5-points | WB, DBS | 5 |
P. falciparum, Dd2 (hrp2–hrp3 +) | PATH | Cell culture | 5-points | WB, DBS | 5 | |
P. falciparum, 3DB5 (hrp2–hrp3–) | PATH | Cell culture | 5-points | WB, DBS | 5 | |
Reactivity to native proteins | P. falciparum | Discovery life science | Clinical | 5-points | WB, DBS | 15 |
P. vivax | Discovery life science | Clinical | 5-points | WB, DBS | 10 | |
P. malariae | Discovery life science | Clinical | 5-points | WB, DBS | 10 | |
P. knowlesi (A1-H1) | PATH | Cell culture | 5-points | WB, DBS | 5 | |
Baseline specificity | Negative (a pool of 5) | Â | NA | NA | WB, DBS | 2 |
Total | Â | Â | Â | Â | Â | 77 |